INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 439m ago
House PTR39m ago
SEC 13F38m ago
Robinhood Chain38m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MT
Maurer Michael TCHIEF COMMERCIAL OFFICER
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
80.0K sh
May 26, 2026May 28, 2026
Page 760 of 1737
← PrevNext →
traded May 26, 2026
+2d
SEC Form 4

Evidence

9
MM
Morrell MarthaCHIEF MEDICAL OFFICER
NPCENeuroPace Inc
Tax withholding
F$6,107
358 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
BL
Blomquist Denise L.Chief Accounting Officer
MDTMedtronic plc
Option exercise
M—
1,621 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
LP
Lipman PaulChief Revenue Officer
INFQInfleqtion, Inc.
Option exercise
M$26K
100.0K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
AC
Arias Juan CarlosSee Remarks
FINWFinwise Bancorp
Tax withholding
F$4,872
348 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
CM
Chapman Jeffrey MDirector
CCBCOASTAL FINANCIAL CORP
Grant or award
A—
1,532 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
KH
Kozlov HershDirector
TBBKBancorp, Inc.
Grant or award
A—
3,600 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
MM
Marinaro MichaelEVP, Pres MedSurg and Americas
MDTMedtronic plc
Option exercise
M—
17.1K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
CL
Clayton Natasha LauretteSee Remarks
FINWFinwise Bancorp
Tax withholding
F$27K
1,961 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
MJ
McEntee James J IIIDirector
TBBKBancorp, Inc.
Grant or award
A—
3,600 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
WR
Walter Matthew R.SVP, Chief HR Officer
MDTMedtronic plc
Option exercise
M—
8,449 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
BI
Bell John IrvingDirector
IMCRImmunocore Holdings plc
Grant or award
A—
27.5K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

9
LT
Lahr TroyEVP & Chief Financial Officer
BAHBooz Allen Hamilton Holding Corp
Grant or award
A—
10.0K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$292K
1,438 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

9
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
1,652 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

8
TT
Tray ThomasPrincipal Accounting Officer
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$200K
2,051 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
18.1K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
18.1K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

8
CS
Congdon David SDirector, Executive Chairman
ODFLOLD DOMINION FREIGHT LINE, INC.
Gift
G—
295.7K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

8
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Option exercise
M$210K
266.3K sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

8
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Option exercise
M$185K
233.7K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

6
Beck PeterDirector, CEO
RKLBRocket Lab Corp
Derivative conversion
C—
5.00M sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

5
LD
Lentz DanielCFO & COO
CMRCCommerce.com, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
6,840 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

5
BA
Bonnett Derek AChief Risk Officer
FCBCFIRST COMMUNITY BANKSHARES INC /VA/
Grant or award
A—
1,756 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$51K
972 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

5
LP
Lipman PaulChief Revenue Officer
INFQInfleqtion, Inc.
Option exercise
M$5,200
20.0K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

5
JA
Juskie Jo AnnSVP
KEYSKeysight Technologies, Inc.
Tax withholding
F$48K
136 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

5
BA
Bonnett Derek AChief Risk Officer
FCBCFIRST COMMUNITY BANKSHARES INC /VA/
Option exercise
M—
2,151 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

5
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Grant or award
A—
3,977 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

5
LP
Lipman PaulChief Revenue Officer
INFQInfleqtion, Inc.
Option exercise
M—
20.0K sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$115K
2,100 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

4
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$87K
1,600 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

2
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$49K
764 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

2
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
972 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

2
Beck PeterDirector, CEO
RKLBRocket Lab Corp
Derivative conversion
C—
5.00M sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

2
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
764 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

2
CM
Cohn MatthewDirector
TBBKBancorp, Inc.
Grant or award
A—
2,250 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

1
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$92K
8,726 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence

1
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$63K
5,974 sh
May 27, 2026May 28, 2026
traded May 27, 2026
+1dSEC Form 4

Evidence

1
ST
Sakamoto Ryan T.EVP, Chief Legal Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$9,245
2,914 sh
May 26, 2026May 28, 2026
traded May 26, 2026
+2dSEC Form 4

Evidence